Diabetic Nephropathy

Rationale

The English term Diabetic Nephropathy corresponds to diabetic kidney disease. It is one of the microvascular complications of diabetes mellitus, in which chronic hyperglycemia damages the glomeruli and renal tubules.

Incorrect Options

Diabetic retinopathy refers to retinal involvement and diabetic neuropathy to nerve involvement; each is a distinct microvascular complication affecting a different organ system. Chronic kidney disease (CKD) is a broader diagnosis for which diabetic kidney disease is a leading cause, but the two terms are not synonymous. Hypertensive nephropathy denotes kidney damage caused by chronic hypertension rather than by diabetes.

Pathophysiology of Diabetic Kidney Disease

Several mechanisms act together in the development of diabetic kidney disease. The most critical early change is podocyte injury. Podocytes are epithelial cells that wrap around the glomerular basement membrane and serve as the final barrier preventing filtration of blood proteins through the slit diaphragm formed between their foot processes. Research shows that in the diabetic state, glomerular expression of a protein called PTPRO (Protein Tyrosine Phosphatase Receptor Type O) is significantly reduced ^[1]. Loss of PTPRO activates the c-Abl/p53 signaling pathway, promoting podocyte apoptosis and decreasing expression of nephrin and podocin, the key structural proteins of the slit diaphragm ^[1]. As a result, the glomerular filtration barrier breaks down and albuminuria develops.

In addition, the metabolic derangements of hyperglycemia produce lipotoxicity and oxidative stress. Palmitic acid, a free fatty acid, is particularly lipotoxic to glomerular mesangial cells, driving cell injury and fibrosis ^[4]. The FGF21 (Fibroblast Growth Factor 21)–SIRT1 axis has been identified as protective in this process ^[4].

Tubular injury also contributes importantly to disease progression. Recent work demonstrates that the complement protein C1QA (Complement Component C1q A Chain) promotes tubular epithelial cell injury under high-glucose conditions by mediating endoplasmic reticulum stress (ERS) ^[3]. Endoplasmic reticulum stress triggers the unfolded protein response, leading to cellular dysfunction and apoptosis.

Clinical Application and Nursing Care

Diabetic kidney disease is asymptomatic early on, so detection at the microalbuminuria stage with aggressive intervention is essential. Studies indicate that diabetic kidney disease is an early complication of diabetes and that renoprotective mechanisms exist independent of glycemic control ^[2]. Cafestol activates the Keap1-Nrf2 axis to strengthen antioxidant defenses, attenuating renal oxidative stress, inflammation, fibrosis, and apoptosis without directly affecting blood glucose levels ^[2]. This suggests that glycemic control alone may not adequately protect the kidneys and that additional strategies such as oxidative stress management are needed.

In clinical practice, routine monitoring of the urine albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) is essential. Because the risk of chronic kidney disease rises in patients with type 2 diabetes who have a higher body mass index (BMI), weight management and lifestyle modification are central to prevention ^[4].